Literature DB >> 8134572

Pustulotic arthroosteitis: spectrum of bone lesions with palmoplantar pustulosis.

A Kasperczyk1, J Freyschmidt.   

Abstract

PURPOSE: To discuss the association of palmoplantar pustulosis (PPP) with sternocostoclavicular hyperostosis (SCCH) and other infection- or tumor-simulating bone lesions.
MATERIALS AND METHODS: From 1989 to 1992, 25 patients (11 men and 14 women, aged 19-69 years [mean, 42 years]) with pustulotic arthroosteitis (PAO) and SCCH were seen. Findings were accumulated to determine the concomitant findings of other bone lesions.
RESULTS: Thirteen patients with skeletal lesions had proved PPP. Eleven of these patients also had SCCH, four had sacroiliitis, six had spondylitis, and six had tumorlike manifestations in the appendicular skeleton. In another 12 patients with SCCH, none had proved PPP but four had psoriasis. Fifteen of 25 patients with SCCH had skin disease. Seven of the 25 patients had only one site of bone involvement (six had SCCH and one had spondylitis); all other patients (including the six with tumor-simulating extraaxial lesions) had more than one skeletal site of bone involvement.
CONCLUSION: Because radiologists play the key role in the diagnosis of PAO, awareness of the possibility of benign disease is necessary to obviate certain diagnostic or therapeutic procedures.

Entities:  

Mesh:

Year:  1994        PMID: 8134572     DOI: 10.1148/radiology.191.1.8134572

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Acquired hyperostosis syndrome--AHYS--(sternocostoclavicular hyperostosis, pustulotic arthro-osteitis, SAPHO-syndrome): bone scintigraphy of the anterior chest wall.

Authors:  W Dihlmann; S W Dihlmann; L Hering
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

2.  Aseptic osteomyelitis of the ilium in the palmoplantar pustulosis.

Authors:  J Belzunegui; A Oñatibia; J Cancio; J M Pego; E Uriarte
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

3.  C1-C2 spondylodiscitis in an adult with SAPHO syndrome: an unusual presentation.

Authors:  Ghita Harifi; Ahlam Belkhou; Imane El Bouchti; Meryem Ouali Idrissi; Najat Chérif Idrissi; Ahmed Ousehal; Selma El Hassani
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

4.  Spondylodiscitis in SAPHO syndrome. A series of eight cases.

Authors:  E Toussirot; J L Dupond; D Wendling
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

Review 5.  Percutaneous bone biopsy, techniques and indications.

Authors:  W Berning; J Freyschmidt; H Ostertag
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 6.  SAPHO: syndrome or concept? Imaging findings.

Authors:  J W S Earwaker; A Cotten
Journal:  Skeletal Radiol       Date:  2003-04-29       Impact factor: 2.199

7.  Unveiling the 'unique bone': a study of the distribution of focal clavicular lesions.

Authors:  S Suresh; A Saifuddin
Journal:  Skeletal Radiol       Date:  2008-05-16       Impact factor: 2.199

Review 8.  Imaging of the seronegative anterior chest wall (ACW) syndromes.

Authors:  Giuseppe Guglielmi; Giacomo Scalzo; Alessia Cascavilla; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

9.  Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up.

Authors:  Timm Kirchhoff; Sonja Merkesdal; Herbert Rosenthal; Mathias Prokop; Ajay Chavan; Annette Wagner; Uwe Mai; Michael Hammer; Henning Zeidler; Michael Galanski
Journal:  Eur Radiol       Date:  2003-03-13       Impact factor: 5.315

10.  The psychological burden of an initially unexplained illness: patients with sternocostoclavicular hyperostosis before and after delayed diagnosis.

Authors:  Willem A van der Kloot; Neveen A T Hamdy; Laurian C S Hafkemeijer; Femke M C den Dulk; Sadhna A Chotkan; Arnold A P van Emmerik; Ad A Kaptein
Journal:  Health Qual Life Outcomes       Date:  2010-09-09       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.